Urinary Tract Infection Treatment Market, By Drug Type (Penicillin & Combinations (Amoxicillin, "Amoxicillin+ Clavulanate, Potassium", Others)), Quinolones (Ciprofloxacin, Levofloxacin, Nalidixic acid, Norfloxacin, Others), Cephalosporin (Ceftriaxone, Cef

Urinary Tract Infection Treatment Market, By Drug Type (Penicillin & Combinations (Amoxicillin, "Amoxicillin+ Clavulanate, Potassium", Others)), Quinolones (Ciprofloxacin, Levofloxacin, Nalidixic acid, Norfloxacin, Others), Cephalosporin (Ceftriaxone, Cefuroxime, Cefixime, Cephalexin), Aminoglycoside Antibiotics (Amikacin, Gentamicin), "Sulphonamides (Sulfamethoxazole +, Trimethoprim)", Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), Other), By Disease Indication (Complicated UTI, Recurring Complicated UTI, Uncomplicated UTI, Neurogenic Bladder Infections), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. UTI infections are common health problems in females than in males with biologic factors accounting as the major cause. Antibiotics are usually the first line of treatment prescribed by doctors for urinary tract infections. According to the site of manifestation by the microbe, infections are classified as cystitis (bladder), urethritis (urethra), prostatitis (prostate) or pyelonephritis (kidney). Painful and increased frequency of urination, excessive and involuntary passing of urine at night are the common symptoms associated with UTI. Hospitalized patients using urinary catheters are at a higher risk for developing UTI.
Restraints of the Global Urinary Tract Infection Treatment Market
Major factors hampering the growth of the urinary tract infection treatment market during the forecast period constitutes of low adoption of internet in some emerging economies.
Key features of the study:
This report provides in-depth analysis of the global urinary tract infection treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global urinary tract infection treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Cipla Ltd., Johnson & Johnson, Bayer AG, Pfizer Inc., GlaxoSmithKline, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Iterum Therapeutics plc, Novartis AG AstraZeneca Plc, Allecra Therapeutics, Healthy.io, Shionogi Inc., Spero Therapeutics, Inc., and Venatorx Pharmaceuticals.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global urinary tract infection treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Urinary Tract Infection Treatment Market, By Drug Type:
Penicillin & Combinations
Amoxicillin"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
Global Urinary Tract Infection Treatment Market, By Disease Indication:
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
Global Urinary Tract Infection Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Urinary Tract Infection Treatment Market, By Geography:
North America
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Europe
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Cipla Ltd.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Johnson & Johnson
Bayer AG
Pfizer Inc.
GlaxoSmithKline
Boehringer Ingelheim
F. Hoffmann-La Roche Ltd.
Iterum Therapeutics plc
Novartis AG
AstraZeneca Plc
Allecra Therapeutics
Shionogi Inc.
Spero Therapeutics, Inc.
Venatorx Pharmaceuticals.
“*” marked represents similar segmentation in other categories in the respective section.